NO20064332L - Farmasoytisk akseptable salter av clopidogrel - Google Patents

Farmasoytisk akseptable salter av clopidogrel

Info

Publication number
NO20064332L
NO20064332L NO20064332A NO20064332A NO20064332L NO 20064332 L NO20064332 L NO 20064332L NO 20064332 A NO20064332 A NO 20064332A NO 20064332 A NO20064332 A NO 20064332A NO 20064332 L NO20064332 L NO 20064332L
Authority
NO
Norway
Prior art keywords
polymorph
clopidogrel
pharmaceutically acceptable
acceptable salts
called
Prior art date
Application number
NO20064332A
Other languages
English (en)
Inventor
Beat Theodor Weber
Karl Michael Levis
Quang Hon Ly
Original Assignee
Siegfried Generics Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Generics Int Ag filed Critical Siegfried Generics Int Ag
Publication of NO20064332L publication Critical patent/NO20064332L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Polymorfe former av (+)-(S)-Clopidogrel-hydrogenbromid kalt polymorf "Form A", polymorf "Form B", polymorf "Form C", polymorf "Form D", polymorf "Form W", og polymorf "Form F", og polymorfe former av (+)-(S)-Clopidogrel-napsylat, kalt polymorf "Form A" og polymorf "Form B" og som skiller seg fra hverandre ved deres pulver-røntgen-diagrammer (XRPD); såvel som saltene Clopidogrel-besylat, Clopidogrel-tosylat og Clopidogrel-oksalat og fremgangsmåter for fremstilling av disse forbindelsene.
NO20064332A 2004-02-24 2006-09-25 Farmasoytisk akseptable salter av clopidogrel NO20064332L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3002004 2004-02-24
PCT/CH2005/000086 WO2005080890A1 (de) 2004-02-24 2005-02-16 Pharmakologisch akzeptierbare salze von clopidogrel

Publications (1)

Publication Number Publication Date
NO20064332L true NO20064332L (no) 2006-11-21

Family

ID=34866028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064332A NO20064332L (no) 2004-02-24 2006-09-25 Farmasoytisk akseptable salter av clopidogrel

Country Status (10)

Country Link
US (1) US20070249660A1 (no)
EP (1) EP1720884A1 (no)
JP (1) JP2007523203A (no)
CN (1) CN1922188A (no)
AU (1) AU2005214469A1 (no)
CA (1) CA2557256A1 (no)
NO (1) NO20064332L (no)
RU (1) RU2006133842A (no)
TW (1) TW200540171A (no)
WO (1) WO2005080890A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2562532C (en) * 2004-04-09 2010-02-16 Hanmi Pharm. Co., Ltd. Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
EA010829B1 (ru) 2004-04-20 2008-12-30 Санофи-Авентис Клопидогрель и его полиморфные формы
KR20070012675A (ko) * 2004-04-20 2007-01-26 사노피-아벤티스 메틸(+)-(Ｓ)-α-(2-클로로페닐)-6,7-디히드로티에노[3,2-Ｃ]피리딘-5(4Ｈ) 아세테이트 히드로브로마이드, 클로피도그렐히드로브로마이드의 다형성 형태
GB0418580D0 (en) * 2004-08-21 2004-09-22 Ivax Pharmaceuticals Sro Clopidogrel salt
ES2391410T3 (es) * 2005-09-05 2012-11-26 Cadila Healthcare Limited Procedimientos para la preparación de diferentes formas de (s)-(+)-clopidogrel besilato
KR100945062B1 (ko) 2006-03-22 2010-03-05 한미약품 주식회사 클로피도그렐 1,5-나프탈렌디술폰산염 및 이의 수화물의제조방법
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
CN104478868A (zh) * 2009-02-27 2015-04-01 奥索-麦克尼尔-詹森药品公司 Hcv大环抑制剂的无定形盐
CN102199161B (zh) * 2011-03-30 2013-07-03 天津红日药业股份有限公司 一种苯磺酸氯吡格雷晶型ⅰ及其制备方法和用途
CN104193762B (zh) * 2014-08-04 2017-02-15 浙江车头制药股份有限公司 一种制备苯磺酸氯吡格雷晶型ⅲ的方法
CN104610275B (zh) * 2015-02-06 2017-07-07 符健 一种2，5‑二羟基苯磺酸氯吡格雷及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
EP1927595B1 (en) * 2003-04-25 2013-03-06 Cadila Healthcare Limited Salts of clopidogrel and process for preparation

Also Published As

Publication number Publication date
JP2007523203A (ja) 2007-08-16
CA2557256A1 (en) 2005-09-01
RU2006133842A (ru) 2008-03-27
AU2005214469A1 (en) 2005-09-01
EP1720884A1 (de) 2006-11-15
US20070249660A1 (en) 2007-10-25
WO2005080890A9 (de) 2005-11-17
TW200540171A (en) 2005-12-16
WO2005080890A1 (de) 2005-09-01
CN1922188A (zh) 2007-02-28

Similar Documents

Publication Publication Date Title
MX2007006630A (es) Metodo para preparar n-fenilpirazol-1-carboxamidas.
IL183237A0 (en) Polymorphs of memantine hydrochloride
IL183568A (en) Process for making 7,8-dihydro-5 h-patridine-6-onh
IL172357A0 (en) Method for the production of substituted 3-aryl-butyl amine compounds
PL378342A1 (pl) Pochodne 2-piperydonu jako agoniści prostaglandyn
SG170054A1 (en) Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
IL183700A0 (en) Process for production of (4,5-dihydroisoxazol-3-yl)thio-carboxamidine salts
IL192147A0 (en) Method for selectively producing primary amine compound
NO20064332L (no) Farmasoytisk akseptable salter av clopidogrel
TW200720246A (en) Novel process for the preparation of acid chlorides
TW200740769A (en) Novel process
SG144914A1 (en) A method for the preparation of enantiomerically pure mirtazapine
IL179107A0 (en) Method for preparing n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives
IL192151A0 (en) Method for producing primary amine compound
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
TW200621756A (en) Method for manufacturing enantiomeric imidazole compounds
IL179141A (en) Biotransformation of colchicinoid compounds
TW200630369A (en) Process for preparing purine compounds
EP1801089A4 (en) METHOD FOR PRODUCING A HYDROXYL COMPOUND
DE602006013828D1 (en) 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren
IL185635A0 (en) Method for preparing enantiomerically pure 4-pyrrolidinophenyl, benzyl, ether derivatives
PL369253A1 (pl) Sposób otrzymywania złożonych 2-deoksy-2-jodopiranozydów o wysokiej czystości, szczególnie Annamycyny o czystości farmaceutycznej
TWI315543B (en) Lithoraphic process for multi-etching steps by using single reticle
GB0522075D0 (en) Process for preparing almodipline mesylate monohydrate
MXPA05011169A (es) Metodo para sintetizar derivados de 5-cloro-1-aril-4 -(4, 5-diciano- 1h-imidazol-2-il)- 3-alquil -1h-pirazola.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application